Current Report Filing (8-k)
September 16 2016 - 8:22AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of
earliest event reported): September 15, 2016
MEDICAL INNOVATION HOLDINGS,
INC.
(Exact name of
Registrant as specified in its charter)
Colorado
|
000-27211
|
84-1469319
|
(State or Other
Jurisdiction of Incorporation or Organization)
|
(Commission File
Number)
|
(I.R.S. Employer
Identification No.)
|
5805 State Bridge Road, Suite
G-328, Duluth, GA 30097
(Address of Principal
Executive Offices)
(866) 883-3793
(Registrant's Telephone
Number, Including Area Code)
MEDINA INTERNATIONAL HOLDINGS, INC.
(Former Name or Former
Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions (see General Instruction A.2.
below):
[_] Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
[_] Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
SECTION 3 - SECURITIES
AND TRADING MARKETS
Item 3.03 - Material Modification to Rights of
Security Holders
Pursuant to a Definitive
14C filed with the Securities and Exchange Commission on August 8, 2016, the
directors approved and the majority shareholders voted to approve, the
following:
#1
: To authorize a reverse
split of the common stock issued and outstanding on a one new share for ten
(10) old shares basis. Fractional shares will be rounded to the next
whole share. The
Stock symbol remains MIHI. This action required an amendment to the Articles of
Incorporation, which was effective on September 15, 2016, and required the
approval of the Financial Industry Regulatory Authority ("FINRA") which was
approved and effective September 15, 2016.
A copy of the filed
Amendment to the Articles of Incorporation is attached hereto as Exhibit
3(i).2.
SECTION 5 - CORPORATE
GOVERNANCE AND MANAGEMENT
Item 5.03 - Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal Year
Effective September 15,
2016, the Company filed an Amendment to the Articles of Incorporation with the
Secretary of State of Colorado regarding:
#1
: To authorize a reverse
split of the common stock issued and outstanding on a one new share for ten
(10) old shares basis. Fractional shares will be rounded to the next
whole share. The
Stock symbol remains MIHI. This action required an amendment to the Articles of
Incorporation, which was effective on September 15, 2016, and required the
approval of the Financial Industry Regulatory Authority ("FINRA") which was
approved and effective September 15, 2016.
#2
: To authorize the Board
of Directors to change the name of the corporation to Medical Innovation Holdings,
Inc. This Action required an Amendment to the Articles of Incorporation, which
was effective on September 15, 2016, and required the approval of the Financial
Industry Regulatory Authority ("FINRA") which was approved and effective
September 15, 2016.
A copy of the filed
Amendment to the Articles of Incorporation is attached hereto as Exhibit
3(i).2.
Item 5.07 - Submission
of Matter to a Vote of Security Holders
On August 8, 2016, the
Company filed a Definitive 14C with the Securities and Exchange Commission and
mailed to shareholders notifying shareholders of record that the directors
approved and the majority shareholders voted to approve the following
amendments to the Articles of Incorporation:
#1
: To authorize a reverse
split of the common stock issued and outstanding on a one new share for ten
(10) old shares basis. Fractional shares will be rounded to the next
whole share. (This action required an amendment to the Articles of
Incorporation and the approval of the Financial Industry Regulatory Authority
("FINRA")).
#2
: To authorize the Board
of Directors to change the name of the corporation to Medical Innovation Holdings,
Inc. (This Action required an Amendment to the Articles of Incorporation and
the approval of the Financial Industry Regulatory Authority ("FINRA")
The actions were
approved by a vote of 298,000,000 (84.86% of the outstanding common shares) in
favor of the proposals.
SECTION 8 - OTHER EVENTS
Item 8.01- Other Events
Effective September 15,
2016, FINRA approved the name change and the 1 for 10 reverse split. The
Company's stock continues to trade under the symbol MIHI, but with a "D" suffix
for twenty days.
SECTION 9 - FINANCIAL
STATEMENTS AND EXHIBITS
Item
9.01 Financial Statements and Exhibits
(d)
Exhibits. The following is a complete list of exhibits filed as part of this
Report. Exhibit numbers correspond to the numbers in the exhibit table of Item
601of Regulation S-K.
Exhibit No.
|
|
Description
|
3(i).2
|
|
Amendment
to Articles of Incorporation effective September 15, 2016
|
|
|
|
|
|
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
Medical
Innovation Holdings, Inc.
By:
____
/s/
Arturo Sanchez
________________
Arturo
Sanchez
Title: CEO
Date: September
15, 2016